Forty Seven Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 28, 2019

NEXT STORY
Chiasma Announces Three Poster Presentations at ENDO 2019
PREV STORY
Gritstone Oncology Announces First Patient Dosed in a Clinical Study Evaluating its Personalized Immunotherapy, GRANITE-001
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Silence Therapeutics and Mallinckrodt Initiate Work on Third Target as Part of Ongoing RNAi Research Collaboration for Complement-Mediated Diseases

author_avatar
NASDAQ Market News

HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

author_avatar
NASDAQ Market News

Global Ultrasound Devices Market expected to reach USD 9.50 billion by 2021: Zion Market Research

Sarasota, FL, Nov. 16, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new ...

author_avatar
NASDAQ Market News